roc curve and auc Search Results


90
GraphPad Software Inc roc curve and auc
Roc Curve And Auc, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc curve and auc/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
roc curve and auc - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd area under roc curve (auc) analysis
Area Under Roc Curve (Auc) Analysis, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/area under roc curve (auc) analysis/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
area under roc curve (auc) analysis - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd roc curve (auc) calculation
Roc Curve (Auc) Calculation, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc curve (auc) calculation/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
roc curve (auc) calculation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd roc and calculated the areas under the curves (aucs)
<t>Receiver</t> operating characteristics analysis of serum uric acid to creatinine ratio in predicting the risk of MAFLD in different groups. ( A ) <t>ROC</t> of overall MAFLD. ( B ) ROC of obesity without T 2 DM. ( C ) ROC of non-obesity without T 2 DM. ( D ) ROC of obesity with T 2 DM. ( E ) ROC of non-obesity with T 2 DM.
Roc And Calculated The Areas Under The Curves (Aucs), supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc and calculated the areas under the curves (aucs)/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
roc and calculated the areas under the curves (aucs) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd roc curves and area under the roc curve (auc)
Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent <t>ROC</t> curves, 1 year <t>(AUC</t> = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.
Roc Curves And Area Under The Roc Curve (Auc), supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc curves and area under the roc curve (auc)/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
roc curves and area under the roc curve (auc) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd auc for the roc curves, cutoff values, and test performance characteristics
Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent <t>ROC</t> curves, 1 year <t>(AUC</t> = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.
Auc For The Roc Curves, Cutoff Values, And Test Performance Characteristics, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/auc for the roc curves, cutoff values, and test performance characteristics/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
auc for the roc curves, cutoff values, and test performance characteristics - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd roc curves, the youden index, and the area under the curve (auc)
Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent <t>ROC</t> curves, 1 year <t>(AUC</t> = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.
Roc Curves, The Youden Index, And The Area Under The Curve (Auc), supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc curves, the youden index, and the area under the curve (auc)/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
roc curves, the youden index, and the area under the curve (auc) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc roc construction and auc calculation
Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent <t>ROC</t> curves, 1 year <t>(AUC</t> = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.
Roc Construction And Auc Calculation, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc construction and auc calculation/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
roc construction and auc calculation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc geometric mean of the antibody titers (gmt) with 95% confidence interval (ci)
Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent <t>ROC</t> curves, 1 year <t>(AUC</t> = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.
Geometric Mean Of The Antibody Titers (Gmt) With 95% Confidence Interval (Ci), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/geometric mean of the antibody titers (gmt) with 95% confidence interval (ci)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
geometric mean of the antibody titers (gmt) with 95% confidence interval (ci) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc confidence intervals (ci) using the wilson/brown method and area under curve (auc)
Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent <t>ROC</t> curves, 1 year <t>(AUC</t> = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.
Confidence Intervals (Ci) Using The Wilson/Brown Method And Area Under Curve (Auc), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/confidence intervals (ci) using the wilson/brown method and area under curve (auc)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
confidence intervals (ci) using the wilson/brown method and area under curve (auc) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Ledell Inc area under the roc curve (auc)
Performance analysis of the tested models. Panels A–E report the average <t>ROC</t> curve of the best models. The optimal cutoff is based on the average Youden-Index of each model for all 5-folds. Standard deviation of the optimal cutoff position is reported on the graph. Panel F reports the cumulative average <t>AUC</t> performance as a function of patients’ timeline length.
Area Under The Roc Curve (Auc), supplied by Ledell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/area under the roc curve (auc)/product/Ledell Inc
Average 90 stars, based on 1 article reviews
area under the roc curve (auc) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd roc curves, sensitivity, specificity, and auc calculator
a. Single Prediction analysis. Receiver operating characteristic <t>(ROC)</t> curve analysis. As a single predictor SerpinA5, the <t>AUC</t> = 0.881 (95% CI 0.805–0.956)], with 89.58% sensitivity and 81.25% specificity. b. Combinated Prediction analysis. A combination of plasma SerpinA5, maternal factors and abnormal UtA-PI (above the 95th percentile) enhanced the predictive value for preeclampsia (United AUC was 0.946 (95% CI 0.905–0.988). (Pre-BMI: Pre-pregnancy BMI).
Roc Curves, Sensitivity, Specificity, And Auc Calculator, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/roc curves, sensitivity, specificity, and auc calculator/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
roc curves, sensitivity, specificity, and auc calculator - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Receiver operating characteristics analysis of serum uric acid to creatinine ratio in predicting the risk of MAFLD in different groups. ( A ) ROC of overall MAFLD. ( B ) ROC of obesity without T 2 DM. ( C ) ROC of non-obesity without T 2 DM. ( D ) ROC of obesity with T 2 DM. ( E ) ROC of non-obesity with T 2 DM.

Journal: Diabetes, Metabolic Syndrome and Obesity

Article Title: Association of Uric Acid to Creatinine Ratio with Metabolic Dysfunction-Associated Fatty Liver in Non-Obese Individuals Without Type 2 Diabetes Mellitus

doi: 10.2147/DMSO.S445916

Figure Lengend Snippet: Receiver operating characteristics analysis of serum uric acid to creatinine ratio in predicting the risk of MAFLD in different groups. ( A ) ROC of overall MAFLD. ( B ) ROC of obesity without T 2 DM. ( C ) ROC of non-obesity without T 2 DM. ( D ) ROC of obesity with T 2 DM. ( E ) ROC of non-obesity with T 2 DM.

Article Snippet: To assess the predictive value of sUA/Cr, we examined the receiver operating characteristic (ROC) and calculated the areas under the curves (AUCs) using MedCalc 20.022 statistical software.

Techniques:

Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent ROC curves, 1 year (AUC = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.

Journal: Frontiers in Immunology

Article Title: Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

doi: 10.3389/fimmu.2025.1517971

Figure Lengend Snippet: Identifying T cell exhaustion-associated genes in osteosarcoma and constructing a risk prognostic model. (A) The heatmap of DEGs between TARGET-OS and GTEx databases, with elevated expression depicted in red and diminished expression in blue. (B) The intersection of DEGs and TEXRGs yielded osteosarcoma-associated differentially expressed TEXRGs. (C) The heatmap of osteosarcoma-associated differentially expressed TEXRGs, with heightened expression shown in red and reduced expression in blue. (D) The chord diagram presents the functional enrichment analysis of osteosarcoma-associated differentially expressed TEXRGs. (E) The functional enrichment network and table of osteosarcoma-associated differentially expressed TEXRGs. (F) Univariate Cox regression analysis identified 37 potential prognostic TEXRLs for osteosarcoma, comprising 12 high-risk TEXRLs and 25 low-risk TEXRLs. (G) LASSO regression analysis and determining the optimal penalty parameter for LASSO regression. (H) The survival status map and risk heatmap of risk model TEXRLs in the total sample group. (I) The Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (J) The survival analysis of the complete sample cohort ( p < 0.001), as well as the training cohort ( p < 0.001) and test cohort ( p = 0.005), demonstrated significant disparities in survival outcomes between patients categorized as red high-risk and blue low-risk. (K) Time-dependent ROC curves, 1 year (AUC = 0.821), 3 years (AUC = 0.861), and 5 years (AUC = 0.814). (L) Clinical ROC curves, Risk score (AUC = 0.821), Age (AUC = 0.453), Gender (AUC = 0.464), and Met (AUC = 0.905). (M, N) Univariate and multivariate COX regression analyses in the total sample group.

Article Snippet: ROC curves and area under the ROC curve (AUC) were calculated using MedCalc for Windows version 19.3.0 (MedCalc Software, Ostend, Belgium).

Techniques: Expressing, Functional Assay

Survival prediction validation of risk models in training and testing groups. (A, B) The survival status map and risk heatmap of risk model TEXRLs in the training group. (C) In the training group, the Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (D) Time-dependent ROC curves in the training group, 1 year (AUC = 0.966), 3 years (AUC = 0.993), and 5 years (AUC = 0.994). (E) Clinical ROC curves in the training group, Risk score (AUC = 0.966), Age (AUC = 0.325), Gender (AUC = 0.359), and Met (AUC = 0.856). (F, G) Univariate and multivariate COX regression analyses in the training group. (H, I) The survival status map and risk heatmap of risk model TEXRLs in the test group. (J) In the test group, the Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (K) Time-dependent ROC curves in the test group, 1 year (AUC = 0.667), 3 years (AUC = 0.741), and 5 years (AUC = 0.694). (L) Clinical ROC curves in the test group, Risk score (AUC = 0.667), Age (AUC = 0.603), Gender (AUC = 0.570), and Met (AUC = 0.956). (M, N) Univariate and multivariate COX regression analyses in the test group.

Journal: Frontiers in Immunology

Article Title: Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

doi: 10.3389/fimmu.2025.1517971

Figure Lengend Snippet: Survival prediction validation of risk models in training and testing groups. (A, B) The survival status map and risk heatmap of risk model TEXRLs in the training group. (C) In the training group, the Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (D) Time-dependent ROC curves in the training group, 1 year (AUC = 0.966), 3 years (AUC = 0.993), and 5 years (AUC = 0.994). (E) Clinical ROC curves in the training group, Risk score (AUC = 0.966), Age (AUC = 0.325), Gender (AUC = 0.359), and Met (AUC = 0.856). (F, G) Univariate and multivariate COX regression analyses in the training group. (H, I) The survival status map and risk heatmap of risk model TEXRLs in the test group. (J) In the test group, the Kaplan-Meier survival curve effectively demonstrates that patients in the red high-risk group exhibited a substantially lower overall survival rate compared to those in the blue low-risk group. (K) Time-dependent ROC curves in the test group, 1 year (AUC = 0.667), 3 years (AUC = 0.741), and 5 years (AUC = 0.694). (L) Clinical ROC curves in the test group, Risk score (AUC = 0.667), Age (AUC = 0.603), Gender (AUC = 0.570), and Met (AUC = 0.956). (M, N) Univariate and multivariate COX regression analyses in the test group.

Article Snippet: ROC curves and area under the ROC curve (AUC) were calculated using MedCalc for Windows version 19.3.0 (MedCalc Software, Ostend, Belgium).

Techniques: Biomarker Discovery

Analysis of the prognostic prediction ability of single genes from the risk model. (A) The effect of high AC090559.1 expression on the prognosis of osteosarcoma overall survival is statistically significant. (B) The effect of high AC135178.4 expression on the prognosis of osteosarcoma overall survival is statistically significant. (C) Kaplan-Meier survival curve analysis indicates that the expression level of AL031775.1cannot be used to predict the survival prognosis of osteosarcoma patients. (D) The effect of low LINC01060 expression on the prognosis of osteosarcoma overall survival is statistically significant. (E) The effect of high LINC02777 expression on the prognosis of osteosarcoma overall survival is statistically significant. (F) Kaplan-Meier survival curve analysis indicates that the expression level of PSMB8-AS1 cannot be used to predict the survival prognosis of osteosarcoma patients. (G) Time-dependent ROC curves of AC090559.1, 1 year (AUC = 0.802), 3 years (AUC = 0.693), and 5 years (AUC = 0.607). (H) Time-dependent ROC curves of AC135178.4, 1 year (AUC = 0.680), 3 years (AUC = 0.593), and 5 years (AUC = 0.579). (I) Time-dependent ROC curves of AL031775.1, 1 year (AUC = 0.671), 3 years (AUC = 0.735), and 5 years (AUC = 0.712). (J) Time-dependent ROC curves of LINC01060, 1 year (AUC = 0.522), 3 years (AUC = 0.681), and 5 years (AUC = 0.678). (K) Time-dependent ROC curves of LINC02777, 1 year (AUC = 0.676), 3 years (AUC = 0.709), and 5 years (AUC = 0.663). (L) Time-dependent ROC curves of PSMB8-AS1, 1 year (AUC = 0.698), 3 years (AUC = 0.655), and 5 years (AUC = 0.521).

Journal: Frontiers in Immunology

Article Title: Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target

doi: 10.3389/fimmu.2025.1517971

Figure Lengend Snippet: Analysis of the prognostic prediction ability of single genes from the risk model. (A) The effect of high AC090559.1 expression on the prognosis of osteosarcoma overall survival is statistically significant. (B) The effect of high AC135178.4 expression on the prognosis of osteosarcoma overall survival is statistically significant. (C) Kaplan-Meier survival curve analysis indicates that the expression level of AL031775.1cannot be used to predict the survival prognosis of osteosarcoma patients. (D) The effect of low LINC01060 expression on the prognosis of osteosarcoma overall survival is statistically significant. (E) The effect of high LINC02777 expression on the prognosis of osteosarcoma overall survival is statistically significant. (F) Kaplan-Meier survival curve analysis indicates that the expression level of PSMB8-AS1 cannot be used to predict the survival prognosis of osteosarcoma patients. (G) Time-dependent ROC curves of AC090559.1, 1 year (AUC = 0.802), 3 years (AUC = 0.693), and 5 years (AUC = 0.607). (H) Time-dependent ROC curves of AC135178.4, 1 year (AUC = 0.680), 3 years (AUC = 0.593), and 5 years (AUC = 0.579). (I) Time-dependent ROC curves of AL031775.1, 1 year (AUC = 0.671), 3 years (AUC = 0.735), and 5 years (AUC = 0.712). (J) Time-dependent ROC curves of LINC01060, 1 year (AUC = 0.522), 3 years (AUC = 0.681), and 5 years (AUC = 0.678). (K) Time-dependent ROC curves of LINC02777, 1 year (AUC = 0.676), 3 years (AUC = 0.709), and 5 years (AUC = 0.663). (L) Time-dependent ROC curves of PSMB8-AS1, 1 year (AUC = 0.698), 3 years (AUC = 0.655), and 5 years (AUC = 0.521).

Article Snippet: ROC curves and area under the ROC curve (AUC) were calculated using MedCalc for Windows version 19.3.0 (MedCalc Software, Ostend, Belgium).

Techniques: Expressing

Performance analysis of the tested models. Panels A–E report the average ROC curve of the best models. The optimal cutoff is based on the average Youden-Index of each model for all 5-folds. Standard deviation of the optimal cutoff position is reported on the graph. Panel F reports the cumulative average AUC performance as a function of patients’ timeline length.

Journal: Scientific Reports

Article Title: Neural networks versus Logistic regression for 30 days all-cause readmission prediction

doi: 10.1038/s41598-019-45685-z

Figure Lengend Snippet: Performance analysis of the tested models. Panels A–E report the average ROC curve of the best models. The optimal cutoff is based on the average Youden-Index of each model for all 5-folds. Standard deviation of the optimal cutoff position is reported on the graph. Panel F reports the cumulative average AUC performance as a function of patients’ timeline length.

Article Snippet: We used the area under the ROC curve (AUC) as our performance measure with confidence intervals computed using the approach reported in LeDell et al . .

Techniques: Standard Deviation

Trained models’ performance based on the area under the  ROC curve (AUC).  CI: confidence interval.

Journal: Scientific Reports

Article Title: Neural networks versus Logistic regression for 30 days all-cause readmission prediction

doi: 10.1038/s41598-019-45685-z

Figure Lengend Snippet: Trained models’ performance based on the area under the ROC curve (AUC). CI: confidence interval.

Article Snippet: We used the area under the ROC curve (AUC) as our performance measure with confidence intervals computed using the approach reported in LeDell et al . .

Techniques:

a. Single Prediction analysis. Receiver operating characteristic (ROC) curve analysis. As a single predictor SerpinA5, the AUC = 0.881 (95% CI 0.805–0.956)], with 89.58% sensitivity and 81.25% specificity. b. Combinated Prediction analysis. A combination of plasma SerpinA5, maternal factors and abnormal UtA-PI (above the 95th percentile) enhanced the predictive value for preeclampsia (United AUC was 0.946 (95% CI 0.905–0.988). (Pre-BMI: Pre-pregnancy BMI).

Journal: PLoS ONE

Article Title: Plasma SerpinA5 in conjunction with uterine artery pulsatility index and clinical risk factor for the early prediction of preeclampsia

doi: 10.1371/journal.pone.0258541

Figure Lengend Snippet: a. Single Prediction analysis. Receiver operating characteristic (ROC) curve analysis. As a single predictor SerpinA5, the AUC = 0.881 (95% CI 0.805–0.956)], with 89.58% sensitivity and 81.25% specificity. b. Combinated Prediction analysis. A combination of plasma SerpinA5, maternal factors and abnormal UtA-PI (above the 95th percentile) enhanced the predictive value for preeclampsia (United AUC was 0.946 (95% CI 0.905–0.988). (Pre-BMI: Pre-pregnancy BMI).

Article Snippet: Receiver operating characteristic (ROC) curves, the sensitivity, specificity, and area under the ROC curve (AUC) were calculated by Medcalc v19.6.1 (MedCalc Software bvba, Ostend, Belgium).

Techniques: Clinical Proteomics